Back to results
US 2020/0048304 A1Published application
Production of heterodimeric proteins
AssigneeGenmab A/S
InventorsMichael GRAMER, Amitava KUNDU, Ewald T. J. VAN DEN BREMER, Muriel VAN KAMPEN, Patrick PRIEM, Aran Frank LABRIJN, Joyce I. MEESTERS, Joost J. NEIJSSEN, Janine SCHUURMAN, Paul PARREN, Patrick VAN BERKEL, Werner L. VOS, Arnout F. GERRITSEN
Life of this patent
Estimating the term…
Abstract
The present invention relates to an in vitro method for production of heterodimeric proteins.
Claims31
An in vitro method for production of a heterodimeric antibody comprising the following steps:
- a) incubating a first homodimeric antibody with a second homodimeric antibody under reducing conditions sufficient to allow reduction of the inter-chain disulfide bonds in the hinge region, and
- wherein said first homodimeric antibody comprises an Fc region of an immunoglobulin, said Fc region comprising a first human IgG1 CH3 region, and said second homodimeric antibody comprises an Fc region of an immunoglobulin, said Fc region comprising a second human IgG1 CH3 region, wherein said first homodimeric antibody has a K409R amino acid substitution (numbering according of the EU Index), and said second homodimeric antibody has an amino acid substitution selected from the group consisting of:
- L368A, L368D, L368E, L368G, L368H, L368I, L368N, L368Q, L368R, L368S, L368T, L368V, L368W, D399A, D399F, D399H, D399K, D399R, D399Y, F405A, F405D, F405E, F405H, F4051, F405K, F405L, F405M, F405N, F405Q, F405S, F405T, F405V, F405W, F405Y, Y407G, Y407L, Y407M, and Y407W (numbering according to the EU Index),
- b) subjecting the composition obtained from step a) to oxidizing conditions sufficient to allow oxidation of cysteines in the heterodimeric antibody to inter-chain disulfide bonds, and
- c) obtaining the heterodimeric antibody.
2 more elements
2-3. (canceled)
11-13. (canceled)
16-17. (canceled)
19-21. (canceled)
24-33. (canceled)
35-37. (canceled)
39-40. (canceled)
43-53. (canceled)
55-62. (canceled)
66-69. (canceled)
Dependencies are inferred from the claim text.